World Health Organization site
Skip Navigation Links

Please fill this short user satisfaction survey


Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 7 September 2021
Main ID:  NCT05023733
Date of registration: 16/08/2021
Prospective Registration: Yes
Primary sponsor: Farhan Karim
Public title: Clinical and Radiographic Outcomes of TLIF w/3D Printed Cellular Implant
Scientific title: Clinical and Radiographic Outcomes of Transforaminal Lumbar Interbody Fusion (TLIF) With a Novel 3D Printed Cellular Titanium Implant
Date of first enrolment: October 1, 2021
Target sample size: 150
Recruitment status: Not yet recruiting
URL:  https://clinicaltrials.gov/show/NCT05023733
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
United States
Contacts
Name:     Farhan Karim, DO
Address: 
Telephone:
Email:
Affiliation:  Hartford Hospital; Hartford Healthcare Bone & Joint Institute
Name:     Bethany Samperi
Address: 
Telephone: 860-972-5978
Email: bethany.samperi@hhchealth.org
Affiliation: 
Name:     Bethany Samperi
Address: 
Telephone: 860-972-5978
Email: bethany.samperi@hhchealth.org
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Skeletally mature adults ages 35 - 80 years of age, inclusive

- Diagnosis of lumbar degenerative disc disease with or without neurologic deficit and
associated central and/or unilateral/bilateral foraminal stenosis

- Subject undergoing one or two level transforaminal lumbar interbody fusion

- Able to read and understand all documents used in this study , including the informed
consent and patient-reported outcome questionnaires

Exclusion Criteria:

- Patients over 80 years of age

- Patients under 35 years of age

- Current smokers

- BMI>42

- Subject has spondylolisthesis > 2

- Subjects with multilevel >2 levels of symptomatic disease

- Subjects with significant spinal deformity

- Subject is pregnant, plans to become pregnant or is breast feeding



Age minimum: 35 Years
Age maximum: 80 Years
Gender: All
Health Condition(s) or Problem(s) studied
Lumbar Spondylolisthesis
Lumbar Spinal Stenosis
Degenerative Disc Disease
Foraminal Stenosis
Intervention(s)
Device: CONDUIT™ Interbody Platform composed of the EIT (Emerging Implant Technologies) Cellular Titanium®
Primary Outcome(s)
Radiographic Fusion [Time Frame: 18 months]
Radiographic Fusion [Time Frame: 24 months]
Secondary Outcome(s)
Intervention Rates [Time Frame: up to 24 months]
Adverse Events [Time Frame: up to 24 months]
Back and Leg Visual Analog Scale (VAS) [Time Frame: 12 months]
Back and Leg Visual Analog Scale (VAS) [Time Frame: 6 months]
Back and Leg Visual Analog Scale [Time Frame: 18 months]
Oswestry Disability Index (ODI) [Time Frame: 12 months]
Oswestry Disability Index (ODI) [Time Frame: 18 months]
Oswestry Disability Index (ODI) [Time Frame: 6 months]
Secondary ID(s)
HHC-2020-0243
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
DePuy Synthes
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history Please fill this short user satisfaction survey